FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used for determining efficiency of treatment of uterine body cancer. Method includes determination of cortisol and tetrahydro-11-deoxycortisol level in day urine 1.5-2 weeks after finishing treatment. Coefficient of ratio of tetrahydro-11-deoxycortisol to cortisol is determined; if ratio value is lower than two, duration of recurrence-free period 5 or more years is predicted, and if ratio is higher than two - development of recurrence in the nearest two years.
EFFECT: application of invention makes it possible to select the most efficient preventive therapeutic impact and eliminate additional toxic action of chemical medications.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF CERVICAL CANCER METASTASES | 2010 |
|
RU2436102C1 |
METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
METHOD OF PREDICTION OF RECURRENT VULVAR CANCER I AND II STAGE | 2015 |
|
RU2608508C1 |
METHOD OF DETERMINING EFFECIENCY OF LARYNX CANCER TREATMENT | 2008 |
|
RU2375003C1 |
METHOD FOR TREATING CANCER OF UTERINE BODY | 2000 |
|
RU2195268C2 |
METHOD FOR PREDICTING COURSE OF TUMOUR PROCESS IN PATIENTS WITH VULVAR CANCER | 2015 |
|
RU2613119C1 |
METHOD FOR TREATING UTERINE CHORIOCARCINOMA CASES | 2006 |
|
RU2318502C2 |
METHOD FOR OVARIAN FIXATION AFTER EXTIRPATION OR SUPRAVAGINAL UTERINE AMPUTATION WITH TUBES | 2004 |
|
RU2271763C2 |
Authors
Dates
2011-07-27—Published
2010-07-05—Filed